By Karen Roman AIR Global PLC (Nasdaq: AIIR) said first half revenue increased 3.7% to $206.9 million due to flavored shisha molasses revenue growth of 3.4% to $204.7 million, while gross profit rose 2.4% to $116.8 million. Adjusted EBITDA was $71.7 million, flat year-over-year, related to lower shipment volumes partially offset by U.S. tariff refunds. […] The post AIR Global Reports 1H Revenue & Gross Profit Growth, Maintains 2026 Guidance appeared first on ExecEdge.

Philip Morris International Inc. (NYSE:PM) and Altria Group, Inc. (NYSE:MO) often come up in the same conversation when investors look for tobacco dividend stocks. Both have long histories of returning cash to shareholders, but their dividend stories are starting to look quite different. Altria offers much more income upfront, while Philip Morris is growing its […]

STORY: Could nicotine pouches become big tobacco's next big growth business? :: Hugo Lhomedet, News reporter :: Gdansk, Poland / August 18, 2026 :: Fast growth and higher margins "Pouches do not produce smoke or vapor, so people can use them in many places where smoking or vaping is restricted. They're also growing faster than vapes or heated tobacco products, and companies say they generate strong margins. "For tobacco groups like Philip Morris and BAT, pouches are also a category where they have strong brands, such as Zyn and Velo. That is different from vaping, where Chinese companies control much of the market." :: Can success travel? "Pouches are already well established in Scandinavia and in the United States. Tobacco companies are now seeing growth in markets including Britain and Poland, but it's not clear that success will travel everywhere. The main obstacle is cultural. In many countries people are used to getting nicotine by inhaling it, through cigarettes or vapes, rather than using a neural product. So to grow beyond those core markets, companies will have to convince consumers to try a very different way of using nicotine." :: Lower health risks? "For smokers who switch completely, pouches may reduce health risks compared with cigarettes. The FDA says that moving fully away from smoking to alternatives, including pouches, can lower risk. An experience in Sweden and Norway suggests oral nicotine products are substantially less harmful than smoking, but they are not risk-free. Health groups and regulators are increasingly worried about youth use, high nicotine strength and marketing practices. So the industry's opportunity also comes with a risk." :: Lighter regulation for now "Pouches have faced lighter regulation than some alternatives in many countries, but that is beginning to change, and tighter rules could slow their growth."

By Hugo Lhomedet and Emma Rumney Aug 18 (Reuters) - Fast-growing nicotine pouches have emerged as one of Big Tobacco's most important bets on a future beyond cigarettes, offering rapid growth,

Philip Morris currently trades at $190.49 per share and has shown little upside over the past six months, posting a middling return of 3.7%. The stock also fell short of the S&P 500’s 13.9% gain during that period.

MO gains 12.8% YTD as smoke-free growth and pricing support earnings, but cigarette declines and oral tobacco weakness temper the outlook.

High-yield ETFs built purely on yield rankings carry a hidden flaw that only shows up when it's too late, and one fund uses a decade-long dividend track record as a filter before yield ever enters the picture.

“Too big to fail” is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their ability to find new sources of growth.

Universal Corp just cratered to a fresh 52-week low while rival tobacco stocks barely flinched, raising an urgent question about whether this leaf tobacco supplier is facing a problem all its own.

MO's smoke-free push gains traction as on! PLUS expands distribution, retail share and product choice in a growing nicotine pouch category.

Philip Morris International (NYSE:PM) just turned a $600 million plan into a $1.2 billion one. On July 27, the company opened its Aurora, Colorado manufacturing campus, a 780,000-square-foot facility built to produce ZYN nicotine pouches. The site went from groundbreaking to commercial shipments in about 19 months, and it opened just weeks after regulators handed […]

Philip Morris International opened a new manufacturing campus in Aurora, Colorado, its largest investment in the U.S. to date. The facility expands domestic production capacity for modern nicotine products, including nicotine pouches sold under the ZYN brand. The Aurora campus is fully integrated, supporting production, logistics, and distribution for the company’s U.S. operations. For investors tracking Philip Morris International, NYSE:PM, the Aurora opening adds context to a stock that...

Philip Morris International (NYSE:PM) is back in focus after Brazil’s landmark public health lawsuit moved a step closer to a liability ruling, putting long running legal risks alongside fresh investment and earnings data. See our latest analysis for Philip Morris International. The share price of Philip Morris International has pulled back in the past week with a 7 day share price return of 6.6% in the red, even after a 90 day share price return of 9.6% and a 1 year total shareholder return...

While Philip Morris International has underperformed the S&P Index over the past year, analysts remain moderately optimistic on its future growth prospects.

MO's pricing power supports smokeable revenues and profit despite declining cigarette volumes and a growing shift toward discount brands.

Both readings are true at once, and the gap between them is the real question for anyone weighing the shares.

Not every fat dividend yield is worth chasing into retirement, and the difference between a durable income stream and a yield trap often hides in details most investors skip past entirely.

Apple, Coca-Cola, and Philip Morris International surged to all-time highs on Tuesday as positive catalysts, strong earnings results, and Wall Street optimism helped the shares higher.

Altria Group (NYSE:MO) sells cigarettes, oral nicotine pouches, and vapor products to adult tobacco users in the US. It’s the parent of Marlboro, still the country’s top-selling cigarette brand. The stock showed up in Donald Trump’s disclosed portfolio, and it’s easy to see the appeal: over 50 straight years of dividend increases and a business […]

Altria stock has surged over 30% this year and still hands investors a yield that dwarfs most of its large-cap peers, but the July 30 earnings report introduces a variable that could push income investors to act now or regret waiting.

Philip Morris just posted a stellar quarter, but instead of raising its forecast, it’s plowing the cash into its U.S. business, and the reason why dominated the call.

The Colorado campus could generate $550 million annually and support 1,000 indirect jobs when fully operational.

Philip Morris International Inc. (NYSE:PM) cut its 2026 adjusted earnings forecast for the third time this year on July 22. Nevertheless, the shares rose about 5% in early trading and closed 3.33% higher at $194.30. The market appears to have looked through the guidance reduction for two reasons. First, the cut reflected a smaller expected currency […]

Turns out losing ground to a rival pouch will make a company spend 9 figures pretty fast

Philip Morris International opened a $1.2 billion manufacturing campus in Colorado, part of the tobacco company’s efforts to expand its Zyn portfolio and meet rising demand for nicotine pouches.

Philip Morris International Inc. (NYSE:PM) is significantly increasing its investment in U.

FDA authorizes Philip Morris International's ZYN nicotine pouches as modified risk tobacco products in the US. ZYN becomes the first and only smoke free nicotine pouch with this regulatory status in the US market. The decision recognizes PMI's harm reduction science and sets a new benchmark for smoke free alternatives. Philip Morris International (NYSE:PM) is expanding its smoke free portfolio, and the FDA's modified risk approval for ZYN puts a fresh spotlight on that shift. The company...

Philip Morris International stock has delivered a very strong 143.6% total return over the past 5 years, yet current valuation checks and an intrinsic value estimate that sits close to the market price suggest the shares no longer look obviously cheap or clearly stretched either. A 143.6% return over 5 years highlights how much value the market has already priced into Philip Morris International, which naturally raises the bar for any further gains. Expectations around the growth and...

Halozyme Therapeutics is at a new high on Friday with earnings due on Aug. 6. Philip Morris International and KeyCorp are also at highs.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

If you're looking for more frequent payouts, you can still enjoy the benefits of low fees and broad diversification, thanks to these top monthly dividend ETFs.

Companies in The News Are: WAB, PM, CME, GEV

Philip Morris International Inc (PM) reports robust Q2 performance with significant gains in smoke-free products and plans for increased US market investments.

By Sinéad Carew and Ragini Mathur July 22 (Reuters) - The Nasdaq led Wall Street lower on Wednesday with a mixed performance from technology stocks, as investors waited for key earnings reports to

Philip Morris and Phillips 66 stocks gained following better-than-expected quarterly earnings and upbeat brokerage commentary, respectively.

Philip Morris International (NYSE:PM) reported what management described as a “very strong” second quarter, with growth led by its international smoke-free products business and a better-than-expected performance in combustibles. Emmanuel Babeau, the company’s group chief financial officer, said Ph

The Dow Jones Industrial Average and the S&P 500 Index were up, while the Nasdaq Composite were down

PM beats second-quarter estimates as adjusted EPS rose 15.2% and organic sales climbed 7.6%, while smoke-free growth supported results.

Philip Morris International (PM) reported better-than-expected results in the previous three-month p

CoreWeave upgraded, IBM initiated: Wall Street's top analyst calls

While the top- and bottom-line numbers for Philip Morris (PM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

(Updates with economic data, recent oil price movement, world markets' overview and corporate stock

Strong quarterly results overshadowed by softer third-quarter outlookPhilip Morris International Inc. (NYSE:PM) reported better-than-expected second-quarter 2026 results on Wednesday, but investors focused on weaker-than-anticipated third-quarter earnings guidance, sending the stock modestly lower.

Philip Morris International reports better-than-expected second-quarter earnings but lowers full-year profit expectations.

Philip Morris (PM) delivered earnings and revenue surprises of +7.84% and +6.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

US equity futures were lower pre-bell Wednesday as oil prices rose following US Secretary of State M

The main US stock measures were pointing lower in Wednesday's premarket activity as investors await

Investing.com -- Philip Morris International Inc. (NYSE: PM) reported second-quarter earnings and revenue that topped consensus expectations on Wednesday, however, shares have edged lower after the company's Q3 earnings guidance missed the consensus estimate.

Philip Morris International recorded higher revenue in the second quarter, boosted by growth in its international business and its Zyn portfolio in the U.S.

Tobacco company Philip Morris International (NYSE:PM) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 10.4% year on year to $11.19 billion. Its GAAP profit of $1.80 per share was 9% below analysts’ consensus estimates.